Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New tools for malaria therapy.

W E Gutteridge1

  • 1UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), Geneva, Switzerland. gutteridgew@who.ch

Parassitologia
|March 4, 2000
PubMed
Summary

New malaria chemotherapies are crucial for disease control. Researchers are exploring diverse strategies, including repurposing old drugs and discovering novel compounds targeting malaria parasites, to overcome treatment challenges.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TDR collaboration with the pharmaceutical industry.

Transactions of the Royal Society of Tropical Medicine and Hygiene·2006
Same author

Designer drugs: pipe-dreams or realities?

Parasitology·1997
Same author

Nitric oxide synthase activity in malaria-infected mice.

Parasite immunology·1996
Same author

Characterization of the enhanced transport of L- and D-lactate into human red blood cells infected with Plasmodium falciparum suggests the presence of a novel saturable lactate proton cotransporter.

The Journal of biological chemistry·1995
Same author

Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro.

Experimental parasitology·1995
Same author

The activity of hydroxynaphthoquinones against Leishmania donovani.

The Journal of antimicrobial chemotherapy·1992

Area of Science:

  • Medicinal Chemistry
  • Parasitology
  • Drug Discovery

Background:

  • Malaria remains a significant global health threat, necessitating urgent development of new chemotherapies.
  • Existing antimalarial drugs face challenges including resistance and toxicity, driving the search for alternatives.

Purpose of the Study:

  • To outline and evaluate various global strategies for discovering and developing novel antimalarial chemotherapies.
  • To address the urgent need for effective malaria prevention and control measures in the absence of vaccines.

Main Methods:

  • Reviewing and categorizing current approaches to antimalarial drug discovery.
  • Examining strategies such as resurrecting forgotten molecules, reformulating existing drugs, and developing new chemical entities (NCEs).
  • Investigating methods to overcome drug resistance and bypass toxicological limitations of current treatments.

Main Results:

  • Multiple avenues are being pursued, including repurposing 'old' chemical entities (OCEs) and identifying NCEs.
  • Strategies focus on targeting known or novel biological targets within the malaria parasite.
  • The study highlights the advantages and limitations associated with each discovery approach.

Conclusions:

  • A multifaceted approach combining various strategies is essential for advancing antimalarial chemotherapy.
  • Continued innovation in drug discovery is vital to combat malaria effectively and overcome resistance.
  • The development of new antimalarial agents is critical for global public health initiatives.

Related Experiment Videos